Chemical ID
ASCORBICACID
Ubiquitous
Yes
| Dosage | Reference |
|---|---|
| LD50=518 (ivn mus) | Jim Duke's personal files. |
| PTD=1-5 g | |
| RDA=30-95 mg/day | |
| RDA=60-100 mg/man/day |
Select a Results View:
Download these results as:
| Activity Sort descending | Dosage | Reference |
|---|---|---|
| Acidulant | FEMA 6,000 | Aloe Research Council - Duke writeup of non-peer reviewd book by Coats and draft by Henry |
| Aldose-Reductase-Inhibitor | not available | Challem, J., Berkson, Burt, and Smith, Melissa Dianne. 2000. Syndrome X - The complete nutritional program to prevent and reservse insulin resistance. John Wiley & Sons, New York. 272 pp. $24.95 |
| Analgesic | 5-10 g/day | Duke, 1992 * |
| Angiotensin-Receptor-Blocker | not available | Duke, 1992 * |
| AntiAGE | 2,000 mg/day | Challem, J., Berkson, Burt, and Smith, Melissa Dianne. 2000. Syndrome X - The complete nutritional program to prevent and reservse insulin resistance. John Wiley & Sons, New York. 272 pp. $24.95 |
| Antiaggregant | not available | Challem, J., Berkson, Burt, and Smith, Melissa Dianne. 2000. Syndrome X - The complete nutritional program to prevent and reservse insulin resistance. John Wiley & Sons, New York. 272 pp. $24.95 |
| Antiaging | 400 mg/day | Duke, 1992 * |
| Antiallergic | not available | Duke, 1992 * |
| Antialzheimeran | 2,000-6,000 mg/day | Duke, 1992 * |
| Antiarthritic | 0.2-1 g/day | Duke, 1992 * |
| Antiasthmatic | 1,000 mg/day | Werbach, M. 1993. Healing with Food. Harper Collins, New York, 443 pp. |
| Antiatherosclerotic | not available | Duke, 1992 * |
| Antibacterial | not available | Davies, S., and Stewart, A. 1990. Nutritional Medicine. Avon Books, New York. 509pp. |
| Anticataract | 400 mg/day | Challem, J., Berkson, Burt, and Smith, Melissa Dianne. 2000. Syndrome X - The complete nutritional program to prevent and reservse insulin resistance. John Wiley & Sons, New York. 272 pp. $24.95 |
| Anticataract | 350 mg/day | Werbach, M. 1993. Healing with Food. Harper Collins, New York, 443 pp. |
| Anticataract | 1 g 3x/day | Duke, 1992 * |
| Anticervicaldysplasic | 1,000-2,000 mg/day | Duke, 1992 * |
| AntiCFS | 500-1,000 mg | Duke, 1992 * |
| Anticlimacteric | 500-5,000 mg/day | Duke, 1992 * |
| Anticold | 1-2 g/man/day | Duke, 1992 * |
Download these results as:
| Plant Name Sort descending | Plant Part | Low Parts Per Million | High Parts Per Million | Standard Deviation | Reference |
|---|---|---|---|---|---|
| Brassica chinensis | Leaf | 450.0 | 9713.0 | 0.5 | Duke, 1992 * |
| Brassica napus var. napobrassica | Root | 250.0 | 2415.0 | 0.7 | USDA's Ag Handbook 8 and sequelae) |
| Brassica nigra | Leaf | 234.0 | 4013.0 | -0.1 | USDA's Ag Handbook 8 and sequelae) |
| Brassica oleracea | Stem | 620.0 | 6890.0 | 1.3 | Duke, 1992 * |
| Brassica oleracea var. botrytis l. | Leaf | 911.0 | 10360.0 | 0.5 | Duke, 1992 * |
| Brassica oleracea var. botrytis l. | Flower | 660.0 | 9300.0 | 2.0 | Duke, 1992 * |
| Brassica oleracea var. capitata l. | Leaf | 190.0 | 6774.0 | 0.2 | Duke, 1992 * |
| Brassica oleracea var. gemmifera | Leaf | 720.0 | 6069.0 | 0.1 | Duke, 1992 * |
| Brassica oleracea var. italica | Leaf | 911.0 | 10360.0 | 0.5 | Duke, 1992 * |
| Brassica oleracea var. sabellica l. | Leaf | 1200.0 | 7720.0 | 0.3 | Duke, 1992 * |
| Brassica oleracea var. viridis l. | Leaf | 233.0 | 3819.0 | -0.1 | Duke, 1992 * |
| Brassica rapa | Root | 210.0 | 2580.0 | 0.8 | Duke, 1992 * |
| Brassica rapa | Leaf | 450.0 | 9713.0 | 0.5 | USDA's Ag Handbook 8 and sequelae) |
| Bromelia pinguin | Shoot | 192.0 | 3430.0 | -0.2 | Duke, 1992 * |
| Brosimum alicastrum | Fruit | 280.0 | 1750.0 | -0.2 | CRC Handbook of Medicinal Herbs and/or CRC Handbook of Proximate Analyses |
| Bupleurum chinense | Root | 132.0 | 1200.0 | 0.0 | Duke, 1992 * |
| Byrsonima crassifolia | Fruit | 840.0 | 9275.0 | 0.3 | Duke, 1992 * |
| Cajanus cajan | Fruit | 320.0 | 1601.0 | -0.2 | Duke, 1992 * |
| Cajanus cajan | Seed | 0.0 | 1279.0 | 0.4 | Duke, 1992 * |
| Calathea macrosepala | Flower | 70.0 | 910.0 | -0.6 | CRC Handbook of Medicinal Herbs and/or CRC Handbook of Proximate Analyses |